Guiguet M - Search Results

1

Muscle and liver lactate metabolism in HAART-treated and naive HIV-infected patients: the MITOVIR study.

Ghosn J, Guiguet M, Jardel C, Benyaou R, Zeller V, Simon A, Valantin MA, Amellal B, Assoumo L, Hogrel JY, Costagliola D, Katlama C, Lombès A. Ghosn J, et al. Among authors: guiguet m. Antivir Ther. 2005;10(4):543-50. Antivir Ther. 2005. PMID: 16038480

2

Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus.

Schnuriger A, Dominguez S, Guiguet M, Harfouch S, Samri A, Ouazene Z, Slama L, Simon A, Valantin MA, Thibault V, Autran B; ANRS HC EP21 study group. Schnuriger A, et al. Among authors: guiguet m. AIDS. 2009 Oct 23;23(16):2079-89. doi: 10.1097/QAD.0b013e328330ed24. AIDS. 2009. PMID: 19710595

3

Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort.

Vogel M, Dominguez S, Bhagani S, Azwa A, Page E, Guiguet M, Valantin MA, Katlama C, Rockstroh JK, Nelson M. Vogel M, et al. Among authors: guiguet m. Antivir Ther. 2010;15(2):267-79. doi: 10.3851/IMP1501. Antivir Ther. 2010. PMID: 20386082 Clinical Trial.

4

Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study.

Dominguez S, Ghosn J, Peytavin G, Guiguet M, Tubiana R, Valantin MA, Murphy R, Bricaire F, Benhamou Y, Katlama C. Dominguez S, et al. Among authors: guiguet m. J Antimicrob Chemother. 2010 Nov;65(11):2445-9. doi: 10.1093/jac/dkq320. Epub 2010 Sep 2. J Antimicrob Chemother. 2010. PMID: 20813809

5

Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression.

Caby F, Guihot A, Lambert-Niclot S, Guiguet M, Boutolleau D, Agher R, Valantin MA, Tubiana R, Calvez V, Marcelin AG, Carcelain G, Autran B, Costagliola D, Katlama C. Caby F, et al. Among authors: guiguet m. Clin Infect Dis. 2016 May 15;62(10):1297-1303. doi: 10.1093/cid/ciw076. Epub 2016 Feb 14. Clin Infect Dis. 2016. PMID: 26908792

6

CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3.

Guiguet M, Kendjo E, Carcelain G, Abgrall S, Mary-Krause M, Tattevin P, Yazdanpanah Y, Costagliola D, Duval X; FHDH-ANRS CO4 Epidemiology Group. Guiguet M, et al. Antivir Ther. 2009;14(3):451-7. doi: 10.1177/135965350901400311. Antivir Ther. 2009. PMID: 19474479

7

The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study.

Lanoy E, Spano JP, Bonnet F, Guiguet M, Boué F, Cadranel J, Carcelain G, Couderc LJ, Frange P, Girard PM, Oksenhendler E, Poizot-Martin I, Semaille C, Agut H, Katlama C, Costagliola D; ONCOVIH study group. Lanoy E, et al. Among authors: guiguet m. Int J Cancer. 2011 Jul 15;129(2):467-75. doi: 10.1002/ijc.25903. Epub 2011 Apr 27. Int J Cancer. 2011. PMID: 21207370 Free article.

8

Plasma cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART.

Palich R, Tubiana R, Abdi B, Mestari F, Guiguet M, Imbert-Bismut F, Katlama C, Bonnefont-Rousselot D, Isnard-Bagnis C. Palich R, et al. Among authors: guiguet m. J Antimicrob Chemother. 2018 Jul 1;73(7):1935-1939. doi: 10.1093/jac/dky112. J Antimicrob Chemother. 2018. PMID: 29688533

9

Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.

Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R; Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Bouteloup V, et al. HIV Med. 2017 Jan;18(1):33-44. doi: 10.1111/hiv.12389. Epub 2016 Sep 14. HIV Med. 2017. PMID: 27625009 Free article.

10

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.

Martinez V, Ta TD, Mokhtari Z, Guiguet M, Miailhes P, Valantin MA, Charlotte F, Bertheau P, Molina JM, Katlama C, Caumes E. Martinez V, et al. Among authors: guiguet m. BMC Res Notes. 2012 Jul 9;5:180. doi: 10.1186/1756-0500-5-180. BMC Res Notes. 2012. PMID: 22490728 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page